• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.69% Nasdaq Up 0.44%

    Seattle Genetics, Inc. (SGEN)

    -NasdaqGS
    47.50 Down 1.43(2.92%) 4:00PM EDT
    Add to Portfolio
    Prev Close:48.93
    Open:48.88
    Bid:36.98 x 100
    Ask:49.99 x 300
    1y Target Est:46.67
    Beta:2.27
    Next Earnings Date:30-Jul-15SGEN Earnings announcement
    Day's Range:46.82 - 49.08
    52wk Range:30.05 - 52.33
    Volume:867,671
    Avg Vol (3m):1,014,270
    Market Cap:5.93B
    P/E (ttm):N/A
    EPS (ttm):-0.66
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SGEN

    Comparison

    Symbol% ChgMkt Cap
    SGENDown 2.92%5.93B
    IMGNDown 1.33%1.54B
    PFEUp 1.16%220.20B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):20.33
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.84
    Quarterly EPS Est (Jun-15) :-0.26
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-3.48

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback